Responsive ROS‐Augmented Prodrug Hybridization Nanoassemblies for Multidimensionally Synergitic Treatment of Hepatocellular Carcinoma in Cascade Assaults
Advanced Science · 2025
DOI: 10.1002/advs.202501420 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Yingjie Zeng und 16 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Prodrugs, Reactive Oxygen Species. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Central Funds Guiding the Local Science and Technology Development of Sichuan Province, National Natural Science Foundation of China, Sichuan Outstanding Youth Fund Project.
Abstract (Originalsprache)
The rapid deterioration and progression of hepatocellular carcinoma (HCC) is intimately associated with copper ion overload, and integrating the cuproptosis mechanism for the treatment of HCC presents a promising prospect. Nevertheless, cell death complexity renders efficient removal of all HCC cells insufficient solely relying on the cuproptosis pathway. Herein, the GSH‐responsive prodrug hybridization nanoassembly CA‐4S 2 @ES‐Cu is exploited, which targets the delivery of copper ions to mitochondria via Elesclomol, contributing to mitochondrial dysfunction and evoking cuproptosis. Simultaneously, CA‐4S 2 depletes GSH to release CA‐4, disrupting microtubule function and suppressing HCC cell proliferation and angiogenesis, to realize a dual attack against copper ion‐mediated deterioration and metastasis of HCC. Furthermore, both in the HCC mouse model synergistically elicit oxidative stress to amplify the cuproptosis effect and release activated immunogenetic cell death to initiate a vigorous antitumor immune response in cascade assault modality. Conclusively, the multilevel synergistic assault penetrates the limitations of single therapy and implements a multidimensional targeted treatment for HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.
- Department of Respiratory Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, China.
- College of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang, 050200, China.
- Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610041, China.
ORCID-Profile: Jun Lu
Förderung
- Central Funds Guiding the Local Science and Technology Development of Sichuan Province
- National Natural Science Foundation of China
- Sichuan Outstanding Youth Fund Project
- Chengdu Science and Technology Bureau
- Sichuan Science and Technology Program
Zitieren
APA
Zeng, Y., Cao, Y., Ren, S., Zhang, C., Liu, J., Liu, K., Wang, Y., Chen, H., Zhou, F., Yang, X., Ge, X., Zhang, T., Wang, T., He, Y., Li, D., Zhang, C., & Lu, J. (2025). Responsive ROS‐Augmented Prodrug Hybridization Nanoassemblies for Multidimensionally Synergitic Treatment of Hepatocellular Carcinoma in Cascade Assaults. Advanced Science. https://doi.org/10.1002/advs.202501420
Vancouver
Zeng Y, Cao Y, Ren S, Zhang C, Liu J, Liu K, et al. Responsive ROS‐Augmented Prodrug Hybridization Nanoassemblies for Multidimensionally Synergitic Treatment of Hepatocellular Carcinoma in Cascade Assaults. Advanced Science. 2025. doi:10.1002/advs.202501420
BibTeX
@article{Zeng2025,
author = {Zeng, Yingjie and Cao, Yuening and Ren, Senmiao and Zhang, Chaozheng and Liu, Jianan and Liu, Ke and Wang, Yan and Chen, Hongyu and Zhou, Fengjiao and Yang, Xiuli and Ge, Xian and Zhang, Tingting and Wang, Tianbao and He, Yao and Li, Defang and Zhang, Chuantao and Lu, Jun},
title = {Responsive ROS‐Augmented Prodrug Hybridization Nanoassemblies for Multidimensionally Synergitic Treatment of Hepatocellular Carcinoma in Cascade Assaults},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202501420}
}
EUVIMED